Michael J. Wartell filed an initial statement of beneficial ownership (Form 3) with the SEC on November 6, 2026, disclosing his status as a newly appointed director of Fractyl Health, Inc. as of November 2, 2026.

Key Highlights

  • Reporting person: Michael J. Wartell, identified as a Director of Fractyl Health, Inc. (NASDAQ:GUTS).
  • Event date: The date of the event requiring the statement was November 2, 2026.
  • No securities held: According to the filing, "No securities are beneficially owned" by Wartell at the time of filing.
  • No derivative securities: Table II of the filing lists no derivative securities, including options, warrants, or convertible instruments.
  • Signed by attorney-in-fact: The form was signed by Harith Rajagopalan, M.D., Ph.D., acting as attorney-in-fact, on November 6, 2026.

Wartell's Initial Ownership Disclosure at Fractyl Health

The Form 3 filed by Michael J. Wartell represents his initial statement of beneficial ownership following his appointment as a director of Fractyl Health, Inc., which trades on NASDAQ under the symbol GUTS. The filing was submitted on November 6, 2026, covering a triggering event dated November 2, 2026. Wartell's address of record is listed as 3 Van De Graaff Drive, Suite 200, Burlington, Massachusetts 01803.

According to the filing, Wartell does not beneficially own any securities of Fractyl Health, either directly or indirectly. Table I, covering non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible instruments, both contain no entries. The filing's remarks section states explicitly: "No securities are beneficially owned."

The form was filed by one reporting person and was signed by Harith Rajagopalan, M.D., Ph.D., as attorney-in-fact under a Power of Attorney referenced as Exhibit 24. The filing does not indicate any other relationship between Wartell and the issuer beyond his role as a director.

What Was Disclosed

Michael J. Wartell submitted a Form 3 disclosing his initial beneficial ownership position upon becoming a director of Fractyl Health, Inc. The filing reports no beneficial ownership of any securities, derivative or otherwise, as of the November 2, 2026 event date.